Gynecologic oncology
-
Gynecologic oncology · Nov 2013
Randomized Controlled Trial Multicenter StudyEpidural analgesia is associated with an increased incidence of postoperative complications in patients requiring an abdominal hysterectomy for early stage endometrial cancer.
Analgesia and early quality of recovery may be improved by epidural analgesia. We aimed to assess the effect of receiving epidural analgesia on surgical adverse events and quality of life after laparotomy for endometrial cancer. ⋯ Epidural analgesia was associated with an increase in any, but not serious, postoperative complications and length of stay after abdominal hysterectomy. Randomised controlled trials are needed to examine the effect of epidural analgesia on surgical adverse events, especially as the present data do not support a quality of life benefit with epidural analgesia.
-
Gynecologic oncology · Nov 2013
Randomized Controlled TrialDevelopment and pilot of an advance care planning website for women with ovarian cancer: a randomized controlled trial.
Few available tools facilitate cancer patients and physicians' discussions of quality of life and end-of-life. Our objective was to develop a web-based tool to promote advance care planning for women with ovarian cancer. ⋯ A website providing information and decisional support for women with ovarian cancer is feasible. Increasing frequency of website use requires future research.
-
Despite the increasing availability of palliative care, oncology providers often misunderstand and underutilize these resources. The goals of palliative care are relief of suffering and provision of the best possible quality of life for both the patient and her family, regardless of where she is in the natural history of her disease. ⋯ Patients with gynecologic malignancies remain an ideal population for palliative care intervention. This review of the literature explores the current state of palliative care in the treatment of gynecologic cancers and its implications for the quality and cost of this treatment.
-
Gynecologic oncology · Oct 2013
Comparative Study Controlled Clinical TrialIntensive complete decongestive physiotherapy for cancer-related upper-limb lymphedema: 11 days achieved greater volume reduction than 4.
Upper-limb lymphedema (ULL) occurs in 15-20% of women after breast-cancer treatment. Its intensive therapy relies on complete (complex) decongestive physiotherapy (CDP), whose duration is not well-established. ⋯ Intensive phase CDP for 11 days obtained significantly more volume reduction of breast cancer-related ULL than 4.
-
Gynecologic oncology · Oct 2013
Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer.
To develop a risk-scoring system (RSS) for the prediction of lymphatic dissemination after hysterectomy in endometrioid endometrial carcinoma (EC). ⋯ Our RSS allows accurate quantification of the probability of lymphatic dissemination and can be used as an adjunct to clinical decision-making after hysterectomy in the absence of staging. TD is an important component of the RSS and should be routinely assessed.